江汉大学学报(自然科学版) ›› 2014, Vol. 42 ›› Issue (3): 90-92.

• 医学 • 上一篇    下一篇

舒洛地特治疗早期糖尿病肾病白蛋白尿

熊萦哲   

  1. 武汉市江夏区第一人民医院 内3科,湖北 武汉 430200
  • 出版日期:2014-06-25 发布日期:2014-07-03
  • 作者简介:熊萦哲(1978— ),女,主治医师,研究方向:中西医结合内科临床。

Treatment of Sulodexide on Albuminuria in Early Diabetic Nephropathy

XIONG Yingzhe   

  1. No.3 Department of Medicine,Jiangxia District First People′ s Hospital ,Wuhan 430200,Hubei ,China
  • Online:2014-06-25 Published:2014-07-03

摘要: 目的 观察舒洛地特治疗早期糖尿病肾病(DN)的白蛋白尿临床疗效。方法 收集早期糖尿病患者65例,随机分成2组,对照组30例,治疗组35例。2组疗程均为8周。对照组,口服氯沙坦片50m g/d,4周。治疗组在常规治疗基础上(氯沙坦钾片50mg,1次/d)加舒洛地特给予600LSU,qd,iv,1次/d,连续2周后,改为舒洛地特片200 mg/d使用6周(共8周)。结果 24 h尿蛋白定量均较治疗前明显降低(P<0. 05或P<0. 01),联合治疗组降低优于对照组。结论 舒洛地特能有效改善早期糖尿病肾病白蛋白尿。

关键词: 舒洛地特, 24 h尿蛋白定量, 糖尿病肾病

Abstract: Objective To study the clinical effect of Sulodexide on albuminuria in early diabetic nephropathy. Methods 65 cases of patients with early diabetic nephropathy were randomly divided to a control group including 30 cases and a treatment group including 35 cases. Both groups have the treatment 8 weeks. The control group orally take Losartan 50 mg/d for 4 weeks. The treatment group on the basis of normal treatment(Losartan potassium 50 mg,one time/d),adds Sulodexide 600 LSU,qd,iv ,one time/d,after 2 weeks,changes to use Sulodexide tablet 200 mg/d for 6 weeks (totally 8 weeks). Results After treatment,B2-MG,BUN,CREA and 24-hour urinary protein is significantly lower than that before treatment for both groups(P<0. 05 or P<0. 01). These indexes of treatment group are better than those of control group. Conclusion Sulodexide can relieve albuminuria effectively in early diabetic nephropathy.

Key words: Sulodexide, 24-hour urinary protein, early diabetic nephropathy

中图分类号: